Nothing Special   »   [go: up one dir, main page]

GB201011411D0 - Therapeutic compounds and their use - Google Patents

Therapeutic compounds and their use

Info

Publication number
GB201011411D0
GB201011411D0 GBGB1011411.4A GB201011411A GB201011411D0 GB 201011411 D0 GB201011411 D0 GB 201011411D0 GB 201011411 A GB201011411 A GB 201011411A GB 201011411 D0 GB201011411 D0 GB 201011411D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1011411.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Georges Hospital Medical School
University of Manchester
Original Assignee
St Georges Hospital Medical School
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Georges Hospital Medical School, University of Manchester filed Critical St Georges Hospital Medical School
Priority to GBGB1011411.4A priority Critical patent/GB201011411D0/en
Publication of GB201011411D0 publication Critical patent/GB201011411D0/en
Priority to PCT/GB2011/001011 priority patent/WO2012004554A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1011411.4A 2010-07-06 2010-07-06 Therapeutic compounds and their use Ceased GB201011411D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1011411.4A GB201011411D0 (en) 2010-07-06 2010-07-06 Therapeutic compounds and their use
PCT/GB2011/001011 WO2012004554A1 (en) 2010-07-06 2011-07-04 Aldehyde compounds as inhibitors of dust mite group 1 peptidase allergen and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1011411.4A GB201011411D0 (en) 2010-07-06 2010-07-06 Therapeutic compounds and their use

Publications (1)

Publication Number Publication Date
GB201011411D0 true GB201011411D0 (en) 2010-08-18

Family

ID=42669292

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1011411.4A Ceased GB201011411D0 (en) 2010-07-06 2010-07-06 Therapeutic compounds and their use

Country Status (2)

Country Link
GB (1) GB201011411D0 (en)
WO (1) WO2012004554A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201001070D0 (en) 2010-01-22 2010-03-10 St George's Hospital Medical School Theraputic compounds and their use
CN103655557B (en) * 2012-09-11 2018-03-30 北京大学 Purposes of the CD38 enzyme inhibitors in airway hyperreactivity disease is treated
WO2016201288A1 (en) 2015-06-12 2016-12-15 Brown University Novel antibacterial compounds and methods of making and using same
CN108348512B (en) * 2015-09-17 2021-09-03 希望之城 PCNA inhibitors
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents
WO2021060048A1 (en) 2019-09-25 2021-04-01 日産化学株式会社 Method for producing peptide compound
WO2024028417A1 (en) 2022-08-03 2024-02-08 Institut National de la Santé et de la Recherche Médicale New composition for the treatment and/or prevention of vitiligo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1011411A (en) 1960-11-13 1965-12-01 B C M Plastic Developments Ltd Improvements in the production of tube bends of reinforced thermo-setting plastic
EP0100673A2 (en) 1982-08-02 1984-02-15 The Research Foundation Of State University Of New York A method of enhancing neurofiber regrowth
DE4331135A1 (en) 1993-09-14 1995-03-16 Bayer Ag New antiviral valine-containing pseudopeptides
US5580854A (en) 1994-03-04 1996-12-03 Mount Sinai School Of Medicine Of The City University Of New York Substrate-related peptidyl-aldehyde inhibitors of the proteolytic activity of the multicatalytic proteinase complex
CA2215211A1 (en) 1995-03-31 1996-10-03 Takeda Chemical Industries, Ltd. Cysteine protease inhibitor
CA2227198A1 (en) * 1995-07-17 1997-02-06 Peptide Therapeutics Limited Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases
WO1997030075A1 (en) 1996-02-16 1997-08-21 Bayer Aktiengesellschaft Oxime- and nitron-substituted pseudopeptides with an anti-viral action
BR9909660A (en) 1998-03-19 2000-11-21 Vertex Pharma Caspase inhibitors
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs

Also Published As

Publication number Publication date
WO2012004554A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
HRP20181615T1 (en) Cytotoxicity-inducing therapeutic agent
EP2542086A4 (en) Compounds and therapeutic uses thereof
EP2739144A4 (en) Compounds and therapeutic uses thereof
IL221511A (en) Bisaryl-linked aryltriazolones and their use
GB201010193D0 (en) Medicinal use
ZA201208173B (en) Peptices and their use
GB201004020D0 (en) New therapeutic use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
ZA201303773B (en) Compounds and their use
EP2575453A4 (en) Oligo-benzamide compounds and their use
GB201011411D0 (en) Therapeutic compounds and their use
HK1184779A1 (en) Novel compound and medical use thereof
EP2615094A4 (en) Sesterterpene compounds and use thereof
GB0913300D0 (en) Therapeutic compounds and their use
GB201020848D0 (en) Compounds and their use
GB201018028D0 (en) Compounds and their use
GB201017822D0 (en) Compounds and their use
GB201005511D0 (en) Compounds and their use
GB201002337D0 (en) Compounds and their use
GB201000308D0 (en) Compounds and their use
GB201000307D0 (en) Compounds and their use
GB201000305D0 (en) Compounds and their use
GB201000309D0 (en) Compounds and their use
GB201021708D0 (en) Novel Therapeutic use
GB201001376D0 (en) New compounds and medical uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)